Eric Luftig - 25 Nov 2024 Form 4 Insider Report for Dorman Products, Inc. (DORM)

Role
Senior Vice President, Product
Signature
/s/ Frank J. Mahr, by Power of Attorney
Issuer symbol
DORM
Transactions as of
25 Nov 2024
Net transactions value
-$232,842
Form type
4
Filing time
27 Nov 2024, 09:35:48 UTC
Previous filing
05 Mar 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DORM Common Stock Options Exercise $229,975 +2,062 +29% $111.53 9,212 25 Nov 2024 Direct F1
transaction DORM Common Stock Sale $291,072 -2,062 -22% $141.16 7,150 25 Nov 2024 Direct
transaction DORM Common Stock Sale $171,745 -1,216 -17% $141.23 5,934 25 Nov 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DORM Employee Stock Option (right to buy) Options Exercise $0 -2,062 -50% $0.000000 2,062 25 Nov 2024 Common Stock 2,062 $111.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount reported includes 299.7243 shares of Dorman common stock acquired by the Reporting Person under Dorman's employee stock purchase plan since the date of the Reporting Person's last Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.21 to $141.253. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option vests in four equal annual installments beginning on January 3, 2023, which is the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by suc